Sec. 3140. Plan to further minimize the use of highly enriched uranium for medical isotopes
249 words·~1 min read·
/bill/115/hr/2810/eh/section-3140·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
The Secretary of Energy, in consultation with the Secretary of State, shall develop and assess a plan, including with respect to the benefits, risks, costs, and opportunities of the plan, to— take additional actions to promote the wider utilization of molybdenum-99 and technetium-99m produced without the use of highly enriched uranium targets, such as, at a minimum, by— eliminating the availability of highly enriched uranium for Mo-99 by buying back U.S.-origin highly enriched uranium in raw or target form from global Mo-99 suppliers; and restricting or placing financial penalties on the import of Mo-99 produced with highly enriched uranium targets; work with global molybdenum suppliers and regulators to reduce the proliferation hazard from reprocessing waste from medical isotope production containing U.S.-origin highly enriched uranium; and ensure an adequate supply of molybdenum-99 and technetium-99 at all times, and both assess and mitigate any risks to such supply during a transition to production without the use of highly enriched uranium.
Not later than April 1, 2018, the Secretary of Energy shall submit to the appropriate congressional committees a report containing the plan and assessment under subsection (a). The report under paragraph
(1)shall be submitted in unclassified form, but may include a classified annex. In this section, the term appropriate congressional committees means— the congressional defense committees; the Committee on Foreign Affairs and the Committee on Energy and Commerce of the House of Representatives; and the Committee on Foreign Relations and the Committee on Energy and Natural Resources of the Senate.